Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Assets Average (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Assets Average for 15 consecutive years, with $6.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 12.9% to $6.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.5 million, a 12.9% decrease, with the full-year FY2024 number at $8.7 million, down 41.86% from a year prior.
  • Assets Average was $6.5 million for Q3 2025 at Creative Medical Technology Holdings, down from $7.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $23.0 million in Q3 2022 to a low of $794825.5 in Q1 2021.
  • A 5-year average of $10.2 million and a median of $8.8 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 1967.6% in 2022, then tumbled 44.23% in 2023.
  • Creative Medical Technology Holdings' Assets Average stood at $7.2 million in 2021, then soared by 189.27% to $20.8 million in 2022, then crashed by 44.23% to $11.6 million in 2023, then tumbled by 41.64% to $6.8 million in 2024, then decreased by 4.42% to $6.5 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Assets Average are $6.5 million (Q3 2025), $7.7 million (Q2 2025), and $7.5 million (Q1 2025).